Profile
Ian Hardy is currently Chairman & Chief Executive Officer at Adaptive Phage Therapeutics, Inc. Formerly, Dr. Hardy was Vice President at Deerfield Management Co. LP (Private Equity) from 2019 to 2025.
Dr. Hardy earned an MBA from Warwick Business School in 2009, an undergraduate degree from the University of Greenwich in 1996, and a doctorate from The University of Nottingham in 2001.
Ian Hardy active positions
| Companies | Position | Start |
|---|---|---|
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies for bacterial infections | Chief Executive Officer | - |
Former positions of Ian Hardy
| Companies | Position | End |
|---|---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Private Equity Investor | 2025-01-31 |
Training of Ian Hardy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Warwick Business School
Warwick Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Greenwich
University of Greenwich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Finance |
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies for bacterial infections | Commercial Services |
- Stock Market
- Insiders
- Ian Hardy
















